| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/30/2004 | US20040265891 use in diagnosis and treatment of cancer, neurodegenerative, or immune disorders; antibodies for immunoassays; drug screening |
| 12/30/2004 | US20040265890 a polypeptide of given amino acid sequence; use as drug target for gastrointestinal disorders; fusion proteins; diagnosis |
| 12/30/2004 | US20040265889 biomarker polypeptides for determining if a test substance will cause hepatotoxicity; kits |
| 12/30/2004 | US20040265888 Binary encoded sequence tags |
| 12/30/2004 | US20040265887 predicting a clinical response to treatment with a chemotherapeutic agent by determining the activity of a gene encoding a DNA repair enzyme |
| 12/30/2004 | US20040265886 microarray of genes each comprising an E-box regulatory sequence in its promoter, interacting with a gene binding to the E-box; kit for detecting changes in gene expression associated with a disease or disorder; primers |
| 12/30/2004 | US20040265885 Peptide nucleic acid (PNA) derivatives which carry one or more phosphoryl radicals at the N terminus of the PNA backbone; can be purified using efficient methods such as chromatography or electrophoresis; use as pharmaceuticals and diagnostic agents |
| 12/30/2004 | US20040265884 Thermocycler |
| 12/30/2004 | US20040265883 using biotinylated oligo d(T) and coupling to a solid support, adding labeled targets to mRNAs of interest, after attachment to beads, unbound and non-specifically bound targets are removed, the mRNA is degraded and the targets are detected with specific probes; simple washings and magnetic separation |
| 12/30/2004 | US20040265882 Diabetes gene |
| 12/30/2004 | US20040265881 angiotensin converting enzyme (ACE) gene; engaging individuals with this genotype in exercise to increase sodium excretion |
| 12/30/2004 | US20040265880 Genomic and proteomic approaches for the development of cell culture medium |
| 12/30/2004 | US20040265877 Methods for detecting presence of cellular constituents |
| 12/30/2004 | US20040265876 Isolated polynucleotide associated with Type II diabetes mellitus and methods of use thereof |
| 12/30/2004 | US20040265874 Pattern recognition method for diagnosis of systemic autoimmune diseases |
| 12/30/2004 | US20040265873 primer which specifically amplifies groEL2 gene; efficiently identify Streptomyces species; identifying a potato scab pathogenic microorganism using a new chronometer molecule as a target gene; groEL2 gene encodes a stress-related protein in bacteria whose function is well conserved |
| 12/30/2004 | US20040265872 nucleotide sequences for polypeptides of the riboflavin specific deaminase family, "ribG"; drug target for use screening for antibacterials; vectors, host cells |
| 12/30/2004 | US20040265871 Ultrasound stimulated DNA hybridization |
| 12/30/2004 | US20040265870 amino-reactive nucleotides such as aminoallyl-dUTP or aminohexyl-dATP for synthesis |
| 12/30/2004 | US20040265869 using gene-specific and/or tissue-specific primers; markers of diabetes; diagnostic/prognostic test; pharmacogenetics |
| 12/30/2004 | US20040265868 Method for the detection of depression related gene transcripts in blood |
| 12/30/2004 | US20040265867 the Riley-Day syndrome; localization will permit prenatal diagnosis in affected families |
| 12/30/2004 | US20040265865 Method for identifying effector molecules |
| 12/30/2004 | US20040265864 removing erythrocytes and blood components other than leukocytes from the whole blood by filtration, then lysing leukocytes of the whole blood, and quantifying the specific mRNA in the lysate; leukocyte filters attached to oligo(dT)-immobilized multi-well plates; use in diagnosis, blood bank screening |
| 12/30/2004 | US20040265862 Screening method for genes of brewing yeast |
| 12/30/2004 | US20040265861 Materials and methods for identifying genes and/or agents that alter replicative lifespan |
| 12/30/2004 | US20040265858 Sets of generalized target-binding e-tag probes |
| 12/30/2004 | US20040265856 5' portion of an intestinal lactase-phlorizine hydrolase (LPH) gene; point mutations; solid phase synthesis; immunoassay; vectors; primers; host cells; antibodies; kits; gene therapy |
| 12/30/2004 | US20040265855 Automatically sampling cells, lysing, separating cell debris/endotoxins, transfecting, then screening libraries via robots (which comprise computers, microtitre plates, and conveyors); solid phase synthesis |
| 12/30/2004 | US20040265853 Detection of Bordetella |
| 12/30/2004 | US20040265852 Diangnosis and treatment of AUR1 and/or AUR2 related disorders |
| 12/30/2004 | US20040265851 Polymerase chain reaction to quantify pyrophosphoric acid production; analyzing actin and/or glyceraldehyde 3-phosphate dehydrogenase levels |
| 12/30/2004 | US20040265850 Rapid detection of microorganisms |
| 12/30/2004 | US20040265849 Point mutation analysis of glyceraldehyde-3-phosphate dehydrogenase genes via allele-specific probe hybridization and/or nuclease digestion; kits; drug screening |
| 12/30/2004 | US20040265847 Administering zinc binding agent (sodium citrate) to modulate interaction within central nervous system between zinc and/or heparin with amyloid precursor proteins |
| 12/30/2004 | US20040265846 Screening point mutations to diagnose cardiovascular diseases, psychiatric diseases, or cancer; binding proteins; monoclonal antibodies; kits |
| 12/30/2004 | US20040265845 Amplifying nucleic acid targets from panels containing markers such as antigens, binding proteins, and/or tyrosinase; reverse transcriptase-polymerase chain reaction (RT-PCR); kits |
| 12/30/2004 | US20040265844 Integrated high throughput system for the analysis of biomolecules |
| 12/30/2004 | US20040265843 Integrated high throughput system for the analysis of biomolecules |
| 12/30/2004 | US20040265842 Mixture contains oligonucleotide probes which hybridize to polymorphism in DNA sample, amplified mixture of DNA isolated from genome via cleaving with restriction endonucleases providing fragments, and ligated adapter nucleic acids, which is amplified via polymerase chain reaction |
| 12/30/2004 | US20040265841 Analyzing mutations in Myosin Light Chain 2a; titin-related diseases; drug screening; animal models; knockout cells; transgenic zebrafish; antibodies |
| 12/30/2004 | US20040265840 Preservation of RNA quality and content in tissue sections during immunohistochemistry |
| 12/30/2004 | US20040265837 As well as Paget's disease, neurological/neuromuscular diseases, nerve diseases, and/or psychotropic diseases; chloride channel modulators |
| 12/30/2004 | US20040265836 Methods for the identification of inhibitors of C4 Long Chain Base Hydroxylase activity in plants |
| 12/30/2004 | US20040265833 Such as carcinomas, adenomas, and polyps; peptide nucleic acids; solid phase synthesis; microarrays; kits |
| 12/30/2004 | US20040265832 Genotyping short terminal repeats/markers; statistical analysis; drug screening |
| 12/30/2004 | US20040265830 Methods for identifying differentially expressed genes by multivariate analysis of microaaray data |
| 12/30/2004 | US20040265829 Identification of genes involved in restenosis and in atherosclerosis |
| 12/30/2004 | US20040265827 Treating or diagnosing cancer or a urological disorder by administering antibodies that bind to human steroid 5-alpha reductase gene products or antisense oligonucleotides that regulate expression of a gene encoding the reductase; screening for agents which decrease extracellular matrix degradation |
| 12/30/2004 | US20040265826 Method for sequencing nucleic acids |
| 12/30/2004 | US20040265825 Methods and compositions for diagnosing and treating a subject having depression |
| 12/30/2004 | US20040265824 Secreted and cell surface genes expressed in benign and malignant colorectal tumors |
| 12/30/2004 | US20040265823 Method of judging mismatch between single-stranded nucleic acid molecules |
| 12/30/2004 | US20040265822 Method of detecting, identifying and counting enteritis vibrio using gene (rpod) sequences encoding rna polymerase sigma 70 factor |
| 12/30/2004 | US20040265821 Rna amplication system using plant components in animal cells |
| 12/30/2004 | US20040265820 Method of determining susceptibility to prion disease |
| 12/30/2004 | US20040265819 Uricosuric regulating action using protein comprising an amino acid sequence represented by SEQ ID NO:1 or an amino acid sequence derived therefrom being capable of transporting uric acid and its analogs; cardiovascular disorders; gout; hypotensive agents; nucleotide sequences; antibodies; modulators |
| 12/30/2004 | US20040265818 Histidine phosphatase interacting protein with 180kd |
| 12/30/2004 | US20040265816 Method of judging risk of side effects of remedys for rheumatoid arthritis (ra) |
| 12/30/2004 | US20040265815 Method for determination of telomere length |
| 12/30/2004 | US20040265814 Method for detecting cytosine methylation by comparatively analysing single strands of amplificates |
| 12/30/2004 | US20040265813 genes coding for nucleic acid metabolism, gene repair and drug resistance enzymes; performing Northern hybridization to RNA collected from tumor cells; thymidylate synthase, dihydropyrimidine dehydrogenase, thymidine kinase |
| 12/30/2004 | US20040265811 Optical biosensor with enhanced activity retention for detection of halogenated organic compounds |
| 12/30/2004 | US20040265810 Contacting with a solid support coupled to a chemical comprising a cleavable functional group; mass spectrometry tag which transfers to the polypeptide upon cleavage; allows quantitative analysis of complex mixtures of analytes |
| 12/30/2004 | US20040265807 Enzymes |
| 12/30/2004 | US20040265804 Method for identifying metastatic tumor cells |
| 12/30/2004 | US20040265803 for the prevention, diagnosis and/or therapy of MSI+ tumors; antibodies against the gene product; use as antitumor agents or vaccines |
| 12/30/2004 | US20040265802 Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines |
| 12/30/2004 | US20040265796 Methods and kits for detecting SARS-associated coronavirus |
| 12/30/2004 | US20040265795 staining with a fluorochromic or fluorogenic substance which binds to the cholesterol-containing envelope and quantitatively determining the fluorescence signals of the individual particles under a fluorescence microscope |
| 12/30/2004 | US20040265794 Genotyping kit for diagnosis of human papilloma virus infection |
| 12/30/2004 | US20040265791 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products |
| 12/30/2004 | US20040265790 Methods and compositions for modulating T lymphocytes |
| 12/30/2004 | US20040265789 screening for herbicides by determining if a test compound binds to 3-oxo-5-alpha-steroid 4-dehydrogenase (DET2); binding compounds are potential herbicides; DET2 is essential enzyme for plant growth |
| 12/30/2004 | US20040265787 Immortalized human keratinocyte cell line |
| 12/30/2004 | US20040265786 Method and formulation for lyophilizing cultured human cells to preserve RNA and DNA contained in cells for use in molecular biology experiments |
| 12/30/2004 | US20040265440 Food borne pathogen sensor and method |
| 12/30/2004 | US20040265332 BASB029 polynucleotide(s) and polypeptides from Neisseria meningitidis |
| 12/30/2004 | US20040265320 Administering a compound selected from 3-O-(3',3'-dimethylsuccinyl) betulinic acid, 3-O-(3',3'-dimethylsuccinyl) betulin, 3-O-(3',3'-dimethylglutaryl) betulin, 3-O-(3',3'-dimethylsuccinyl) dihydrobetulinic acid, 3-O-(3',3'-dimethylglutaryl) betulinic acid, (3',3'-dimethylglutaryl) dihydrobetulinic acid |
| 12/30/2004 | US20040265316 An antibody which specifically binds to a Fhit (fragile histidine triad) protein or derivative |
| 12/30/2004 | US20040265313 Methods to regulate biofilm formation |
| 12/30/2004 | US20040265303 Anti-CCR2 antibodies and methods of use therefor |
| 12/30/2004 | US20040265300 Targeting cancer cell; induction or prevention of apoptosis in eukaryotic cells; a fusion peptide contains a viral apoptotic peptide and an antibody fragment; recombinant host cell comprising the vector, encoding chimeric polypeptide; bioassay monitoring apoptosis activity; drug target |
| 12/30/2004 | US20040265295 contacting PIPKI gamma 661 with a test agent in the presence of at least one selected protein, detecting an activity of PIPKI gamma 661, wherein a change the activity of PIPKI gamma 661 as compared to a control is indicative of said agent modulating the activity of PIPKI gamma 661 |
| 12/30/2004 | US20040265287 Myocardial grafts and cellular compositions useful for same |
| 12/30/2004 | US20040265230 Compositions and methods for diagnosing and treating colon cancers |
| 12/30/2004 | US20040263543 Production method and production apparatus of probe carrier |
| 12/30/2004 | US20040262585 Use of dendrimers and poly-branched molecules to enhance signal in fluorescent assay systems |
| 12/30/2004 | US20040262582 Conducting inks |
| 12/30/2004 | US20040261193 Providing a smaller swatch of material comprising a piece of material and a stain, wherein the smaller swatch is capable of fitting into a microtiter plate; fixing the stain to the material; applying an enzyme to the swatch; incubating the swatch and enzyme; measuring the degree of removal of stain |
| 12/30/2004 | DE19963198B4 Verfahren zum topographischen Proteinnachweis an formalinfixierten Gewebeschnitten A method for topographic protein detection in formalin-fixed tissue sections |
| 12/30/2004 | DE19912799B4 Superparamagnetisches Adsorptionsmaterial und seine Verwendung Superparamagnetic adsorption and its use |
| 12/30/2004 | DE10326773A1 Detecting disease recurrence and high stage in bladder carcinoma, comprises using Nucleophosmin/B23 mRNA as a prognostic diagnostic marker to detect progression of the carcinoma |
| 12/30/2004 | DE10326586A1 Verfahren zur Messung und zur Kontrolle der Biofilmbildung in einem Wassersystem A method for measuring and controlling biofilm formation in a water system |
| 12/30/2004 | DE10326302A1 Bi-Fluorophor-markierte Sonden zum Nachweis von Nukleinsäuren Bi-fluorophore-labeled probes for detecting nucleic acids |
| 12/30/2004 | DE10325173A1 Nachweisverfahren für Fibrinogen und/oder Fibrinogen-Derivate Detection methods for fibrinogen and / or fibrinogen derivatives |
| 12/30/2004 | CA2469140A1 Hcv regulated proteins |
| 12/30/2004 | CA2432365A1 Specific method of prostate cancer detection based on pca3, and kits therefore |
| 12/29/2004 | WO2004113919A2 Nano and micro-technology virus detection method and device |
| 12/29/2004 | WO2004113910A1 Devices and methods relating to electrochemical biosensors |